Martin Pruschy
Overview
Explore the profile of Martin Pruschy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1270
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Silginer M, Papa E, Szabo E, Vasella F, Pruschy M, Stroh C, et al.
Acta Neuropathol Commun
. 2023 Mar;
11(1):41.
PMID: 36915128
The hepatocyte growth factor (HGF)/MET signaling pathway has been proposed to be involved in the resistance to radiotherapy of glioblastoma via proinvasive and DNA damage response pathways.Here we assessed the...
12.
Tschanz F, Bender S, Telarovic I, Waller V, Speck R, Pruschy M
Cancer Res Commun
. 2023 Mar;
1(3):164-177.
PMID: 36860547
Significance: The tumor response to radiotherapy is influenced by several factors of the tumor microenvironment. We demonstrate that inhibition of the sheddase ADAM17 by the novel antibody MEDI3622 reduces IR-induced...
13.
Makris G, Kayhan S, Kreuzer M, Rufenacht V, Faccin E, Underhaug J, et al.
Cancer Commun (Lond)
. 2023 Jan;
43(4):508-512.
PMID: 36708276
No abstract available.
14.
Eriksen J, Boldrini L, Gershkevitsh E, Guckenberger M, van der Heide U, Heijmen B, et al.
Tech Innov Patient Support Radiat Oncol
. 2022 Oct;
24:73-77.
PMID: 36247369
Introduction: During the COVID-19 pandemic the ESTRO School who provides international non-profit postgraduate education in Radiation Oncology and related disciplines, including Medical Physics and Radiation Technology, had to close down...
15.
Grzmil M, Boersema P, Sharma A, Blanc A, Imobersteg S, Pruschy M, et al.
J Hematol Oncol
. 2022 Aug;
15(1):123.
PMID: 36045419
The vast majority of our knowledge regarding cancer radiobiology and the activation of radioresistance mechanisms emerged from studies using external beam radiation therapy (EBRT). Yet, less is known about the...
16.
Telarovic I, Yong C, Guckenberger M, Unkelbach J, Pruschy M
Neoplasia
. 2022 Jun;
31:100812.
PMID: 35667149
Radiation-induced lymphopenia is a common occurrence in radiation oncology and an established negative prognostic factor, however the mechanisms underlying the relationship between lymphopenia and inferior survival remain elusive. The relevance...
17.
Deycmar S, Mara E, Kerschbaum-Gruber S, Waller V, Georg D, Pruschy M
Radiat Oncol
. 2022 Apr;
17(1):72.
PMID: 35410422
Objective: Hypersensitivity towards proton versus photon irradiation was demonstrated in homologous recombination repair (HRR)-deficient cell lines. Hence, combined treatment concepts targeting HRR provide a rational for potential pharmaceutical exploitation. The...
18.
Brack E, Bender S, Wachtel M, Pruschy M, Schafer B
Front Oncol
. 2021 Jul;
11:664462.
PMID: 34211841
Fusion-positive rhabdomyosarcoma (FP-RMS) is a highly aggressive childhood malignancy which is mainly treated by conventional chemotherapy, surgery and radiation therapy. Since radiotherapy is associated with a high burden of late...
19.
La Greca Saint-Esteven A, Vuong D, Tschanz F, van Timmeren J, Dal Bello R, Waller V, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34208595
Radiomics supposes an alternative non-invasive tumor characterization tool, which has experienced increased interest with the advent of more powerful computers and more sophisticated machine learning algorithms. Nonetheless, the incorporation of...
20.
Telarovic I, Wenger R, Pruschy M
J Exp Clin Cancer Res
. 2021 Jun;
40(1):197.
PMID: 34154610
Hypoxia in solid tumors is an important predictor of treatment resistance and poor clinical outcome. The significance of hypoxia in the development of resistance to radiotherapy has been recognized for...